A person holds doses of Imvanex vaccine used to protect against Monkeypox virus at the Edison municipal vaccination centre in Paris, France July 27, 2022.A person holds doses of Imvanex vaccine used to protect against Monkeypox virus at the Edison municipal vaccination centre in Paris, France July 27, 2022.

The additional monkeypox vaccine will be made available to local health departments as soon as possible after the FDA approves the shots, according to the nation's top health official.

More allocations of the two-dose vaccine will be announced by the federal government on Thursday. Long lines at clinics and protests in some cities have arisen due to the shortage of vaccine in the U.S.

According to the Centers for Disease Control and Prevention, more than 3,500 cases of monkeypox have been reported in the U.S. Spain has the most monkeypox cases in the world, followed by the U.S.

The Jynneos vaccine is made by a company based in the Danes. The shots had to be approved by the FDA before they could be sold. The FDA reviewed the drugs this month and they can now be given to local authorities.

In a letter to the White House, House Democrats criticized the FDA inspection and called on President Joe Biden to speed up delivery. The facility was inspected by the FDA in July after the global monkeypox outbreak.

It is unclear why the FDA delayed inspection of a stockpile needed for biodefense, and this omission has cost valuable time in the U.S.response to monkeypox. The letter was signed by 48 other members of Congress and was written by two New York congressmen.

After the first confirmed monkeypox case in the U.S., the FDA and HHS worked to quickly approve the facility, according to Dr. Peter Marks.

The House Democrats want the White House to declare a public health emergency and work with Congress to get more funding for the response to the outbreak.

According to the Biden administration, the U.S. has shipped more than 300,000 doses of the vaccine. The US will get an additional 5 million doses through the middle of the next decade.

The Jynneos vaccine was approved by the FDA for people who are at a high risk of exposure to monkeypox. Mild monkeypox is caused by the same family of Viruses. According to the CDC, there is no data on how effective the vaccine is.

Men who have sex with men are at higher risk of being bitten by the monkeypox than women. 98% of the patients who provided demographic information were men who had sex with men, according to the CDC.

The best time to get a vaccine is four days after exposure to monkeypox. Two doses are given in 28 days. The shots may not prevent disease, but they may reduce symptoms.

The CDC recommends that people with confirmed or presumed monkeypox exposure get a vaccine. The U.S. has more than 100 million doses of a vaccine called ACAM2000 that can be used to prevent monkeypox, but it can have serious side effects. People who are HIV-positive, pregnant women, and people with similar skin conditions are not recommended for it.